Literature DB >> 16644675

The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.

Vincenzo Cirulli1, Jessie Zalatan, Michael McMaster, Robyn Prinsen, Daniel R Salomon, Camillo Ricordi, Bruce E Torbett, Paolo Meda, Laura Crisa.   

Abstract

Selective expression of the human class Ib HLA molecule HLA-G in immunologically protected sites and its function in the inhibition of NK and T-cell effector functions support an important role of this molecule in immunoregulation. Here, we demonstrate that HLA-G is constitutively expressed in the endocrine compartment of the human pancreas. Surface expression of this HLA determinant in endocrine cells is regulated in response to growth and inflammatory stimuli. Furthermore, we provide evidence that HLA-G expressed in this tissue may associate with a subset of insulin-containing granules and may be shuttled to the cell surface in response to secretory stimuli. Thus, HLA-G presentation by endocrine cells may be regulated in concert with their secretory activity. These results identify the expression of a major histocompatibility complex locus with putative regulatory functions in human pancreatic islets, a finding with potentially important implications for the progression of autoimmunity as well as for the establishment of transplant tolerance to this tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644675     DOI: 10.2337/db05-0731

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

Review 1.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  The association between the HLA-G 14-bp insertion/deletion polymorphism and type 1 diabetes.

Authors:  H P V Silva; M A G Ururahy; K S C Souza; M B Loureiro; Y M C Oliveira; G H M Oliveira; A D Luchessi; K T C Carvalho; J C O C Freitas; E A Donadi; R D C Hirata; M G Almeida; R F Arrais; M H Hirata; A A Rezende
Journal:  Genes Immun       Date:  2015-10-22       Impact factor: 2.676

Review 3.  Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.

Authors:  Julie B Sneddon; Qizhi Tang; Peter Stock; Jeffrey A Bluestone; Shuvo Roy; Tejal Desai; Matthias Hebrok
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

4.  Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis.

Authors:  E Favoino; I E Favia; S Vettori; C Vicenti; M Prete; G Valentini; F Perosa
Journal:  Clin Exp Immunol       Date:  2015-05-10       Impact factor: 4.330

5.  KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds.

Authors:  Emiliana Weiss; Heloisa S Andrade; Juliana Rodrigues Lara; Andreia S Souza; Michelle A Paz; Thálitta H A Lima; Iane O P Porto; Nayane S B Silva; Camila F Bannwart Castro; Rejane M T Grotto; Eduardo A Donadi; Celso T Mendes-Junior; Erick C Castelli
Journal:  Immunogenetics       Date:  2021-02-17       Impact factor: 2.846

6.  Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC.

Authors:  Rajashree Mishra; Mikael Åkerlund; Diana L Cousminer; Emma Ahlqvist; Jonathan P Bradfield; Alessandra Chesi; Kenyaita M Hodge; Vanessa C Guy; David J Brillon; Richard E Pratley; Michael R Rickels; Adrian Vella; Fernando Ovalle; Ronald I Harris; Olle Melander; Stephen Varvel; Hakon Hakonarson; Phillippe Froguel; John T Lonsdale; Didac Mauricio; Nanette C Schloot; Kamlesh Khunti; Carla J Greenbaum; Knud B Yderstræde; Tiinamaija Tuomi; Benjamin F Voight; Stanley Schwartz; Bernhard O Boehm; Leif Groop; Richard David Leslie; Struan F A Grant
Journal:  Diabetes Care       Date:  2019-12-16       Impact factor: 19.112

7.  Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.

Authors:  Yuki Okushi; Kazuaki Okino; Kiyotaka Mukai; Yuki Matsui; Norifumi Hayashi; Keiji Fujimoto; Hiroki Adachi; Hideki Yamaya; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2017-03-31       Impact factor: 2.801

8.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

Review 9.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.